These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10434583)

  • 41. Clozapine withdrawal symptoms in a Parkinson's disease patient.
    Zesiewicz TA; Borra S; Hauser RA
    Mov Disord; 2002 Nov; 17(6):1365-7. PubMed ID: 12465085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
    Schindehütte J; Trenkwalder C
    Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Parkinsonism following addition of fluoxetine to treatment with neuroleptics or carbamazepine].
    Keppel Hesselink JM
    Ned Tijdschr Geneeskd; 1992 Apr; 136(15):754-5. PubMed ID: 1348574
    [No Abstract]   [Full Text] [Related]  

  • 44. Drug-induced parkinsonism.
    White NJ; Barnes TR
    Lancet; 1982 Jul; 2(8289):99. PubMed ID: 6123834
    [No Abstract]   [Full Text] [Related]  

  • 45. [Drug-induced parkinsonism].
    Ory-Magne F
    Rev Prat; 2020 May; 70(5):475-478. PubMed ID: 33058630
    [No Abstract]   [Full Text] [Related]  

  • 46. Drug-induced parkinsonism: a growing list.
    Martí Massó JF; Carrera N; Urtasun M
    Mov Disord; 1993; 8(1):125. PubMed ID: 8419801
    [No Abstract]   [Full Text] [Related]  

  • 47. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis.
    Teive HA; Troiano AR; Germiniani FM; Werneck LC
    Parkinsonism Relat Disord; 2004 Jun; 10(4):243-5. PubMed ID: 15120099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parkinsonism induced by atypical neuroleptics in a patient with severe iron deficiency.
    Yoshida T; Suzuki G; Nibuya M; Sano SY; Nomura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):29-31. PubMed ID: 15027328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parkinson's disease.
    Barboi AC; Goetz CG
    Clin Neuropharmacol; 1999; 22(4):184-91. PubMed ID: 10442246
    [No Abstract]   [Full Text] [Related]  

  • 50. [An 87-year-old man with mild cognitive impairment, accompanying possible drug-induced parkinsonism].
    Kamiya H; Murayama S; Funabe S; Saito Y; Fukuda T
    Brain Nerve; 2012 Dec; 64(12):1435-42. PubMed ID: 23209072
    [No Abstract]   [Full Text] [Related]  

  • 51. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE; Kuskowski MA; Caligiuri MP
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antipsychotic-induced movement disorders - forgotten but not gone.
    Weiden PJ
    Acta Psychiatr Scand; 2008 Jun; 117(6):401-2. PubMed ID: 18479315
    [No Abstract]   [Full Text] [Related]  

  • 53. Cyanide-induced parkinsonism and F-18 FDG PET/CT findings.
    Sarikaya I; Apaydin H; Topal U; Karaoglan O
    Clin Nucl Med; 2006 Jun; 31(6):363-4. PubMed ID: 16714905
    [No Abstract]   [Full Text] [Related]  

  • 54. [Various diseases simulating parkinsonism].
    Kuzuhara S
    Nihon Naika Gakkai Zasshi; 1994 Apr; 83(4):559-64. PubMed ID: 7963990
    [No Abstract]   [Full Text] [Related]  

  • 55. Prognosis of drug-induced Parkinson's disease.
    Wilson JA; Primrose WR; Smith RG
    Lancet; 1987 Feb; 1(8530):443-4. PubMed ID: 2880234
    [No Abstract]   [Full Text] [Related]  

  • 56. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
    Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R
    J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of drug-induced parkinsonism-like states with a drug used in the therapy of parkinsonism (methixene HCl)].
    Münnich JE
    Med Welt; 1966 Oct; 40():2132-5. PubMed ID: 5920409
    [No Abstract]   [Full Text] [Related]  

  • 58. Quantitative measurement of handwriting in the assessment of drug-induced parkinsonism.
    Caligiuri MP; Teulings HL; Filoteo JV; Song D; Lohr JB
    Hum Mov Sci; 2006 Oct; 25(4-5):510-22. PubMed ID: 16647772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A fatal association between a seizure and drug-induced parkinsonism.
    Lichtigfeld FJ; Gillman MA
    J R Soc Med; 1991 Apr; 84(4):237-8. PubMed ID: 1674007
    [No Abstract]   [Full Text] [Related]  

  • 60. [Trimetazidine-induced parkinsonism].
    Martí Massó JF
    Neurologia; 2004 Sep; 19(7):392-5. PubMed ID: 15273888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.